Empire Genomics | GenomeWeb

Empire Genomics

Empire said it expects to generate $5 million or more in revenues from the Chinese market over the five-year term of the agreement with HemaTone.

The Buffalo, NY-based firm will use the proceeds to grow its marketing, automation, and operations, and to launch additional molecular diagnostic products.

The permit will allow the company to offer DNA sequencing and molecular diagnostics for testing of cancer patients.

The firm's cytogenetic media, immunohistochemistry products, and fish probes have been certified for marketing in Europe.

The acquisition of the molecular diagnostic reagents firm is the first of several that Empire Genomics anticipates in order to accelerate the growth of its business.

NEW YORK (GenomeWeb) – Empire Genomics said today it has tapped Quadpharma to manufacture analyte-specific reagents using current good manufacturing principles for its clients in the research, clinical, and pharmaceutical industries.

NEW YORK (GenomeWeb News) — Rand Capital and SCP Buffalo Incubator Innovate NY Fund said yesterday that they have invested $1 million in privately held molecular diagnostics firm Empire Genomics.

NEW YORK (GenomeWeb News) – Empire Genomics today said that its clinical laboratory facility has received CLIA certification and has been approved by the New York State Department of Health.

The University of Buffalo and its spin-off molecular diagnostics company, Empire Genomics, have announced a partnership with Life Technologies to develop and commercialize sequencing-based tests using the Ion Torrent Proton and PGM.

NEW YORK (GenomeWeb News) – Empire Genomics, the University at Buffalo, and Life Technologies have joined to develop CLIA-certified next-generation sequencing facilities in upstate New York, they announced today.

Pages

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.